AngioDynamics
ANGO
#6717
Rank
$0.25 B
Marketcap
$6.37
Share price
-6.32%
Change (1 day)
-33.37%
Change (1 year)
Categories

P/E ratio for AngioDynamics (ANGO)

P/E ratio as of April 2024 (TTM): 42.5

According to AngioDynamics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.5. At the end of 2022 the company had a P/E ratio of -16.6.

P/E ratio history for AngioDynamics from 2004 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-16.6-40.45%
2021-27.9712.31%
2020-3.43-131.92%
201910.7-73.84%
201841.1-152.11%
2017-78.8264.5%
2016-21.6-69.71%
2015-71.4-160.1%
2014119-148.47%
2013-245569.18%
2012-36.6-164.31%
201157.085.3%
201030.7-19.56%
200938.220.03%
200831.8-168.56%
2007-46.4-227.5%
200636.4-31.52%
200553.2-3.95%
200455.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
10.6-75.14%๐Ÿ‡บ๐Ÿ‡ธ USA
84.0 97.53%๐Ÿ‡บ๐Ÿ‡ธ USA
25.3-40.51%๐Ÿ‡บ๐Ÿ‡ธ USA
42.3-0.51%๐Ÿ‡บ๐Ÿ‡ธ USA
53.4 25.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-49.9-217.36%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.